SNCA and Parkinson disease: Wrasidlo Wrasidlo W W Tsigelny Tsigelny IF IF Price Price DL DL A de novo compound targeting alpha-synuclein improves deficits in models of Parkinson’s disease A de novo compound targeting alpha-synuclein improves deficits in models of Parkinson’s disease Brain Brain 2016 2016 139 139 3217 3217 3236 3236 supplied-pmid 27679481?